Medical News

RSS
Juventas begins enrollment in JVS-100 Phase IIa study for Rutherford Class 4 or 5 CLI

Juventas begins enrollment in JVS-100 Phase IIa study for Rutherford Class 4 or 5 CLI

Coromega introduces emulsified form of omega-3s

Coromega introduces emulsified form of omega-3s

BiO2 Medical receives CE Mark approval for Angel Catheter to prevent PE

BiO2 Medical receives CE Mark approval for Angel Catheter to prevent PE

PGI first quarter net sales increase to $295.2 million

PGI first quarter net sales increase to $295.2 million

Novelos completes I-131-CLR1404 Phase 1b trial on advanced solid tumors

Novelos completes I-131-CLR1404 Phase 1b trial on advanced solid tumors

NSHC, NextGen Healthcare partner to deploy patient management solutions

NSHC, NextGen Healthcare partner to deploy patient management solutions

Derma Sciences first quarter net sales increase 6% to $15.3 million

Derma Sciences first quarter net sales increase 6% to $15.3 million

Svelte completes enrollment in DIRECT drug-eluting stent study

Svelte completes enrollment in DIRECT drug-eluting stent study

Asymptomatic patients can benefit from ExE after coronary revascularization

Asymptomatic patients can benefit from ExE after coronary revascularization

Cyclophosphamide drug makes the bone marrow more tumor-friendly

Cyclophosphamide drug makes the bone marrow more tumor-friendly

Lab21’s HCV drug resistance genotyping receives new patents in the U.S., Europe

Lab21’s HCV drug resistance genotyping receives new patents in the U.S., Europe

InVivo Therapeutics reports net income of $3,150,000 for first quarter 2012

InVivo Therapeutics reports net income of $3,150,000 for first quarter 2012

Harvard cardiologist receives Cedars-Sinai’s Corday Prize in Heart Research

Harvard cardiologist receives Cedars-Sinai’s Corday Prize in Heart Research

Study demonstrates long-term effectiveness of classroom-based drug prevention program

Study demonstrates long-term effectiveness of classroom-based drug prevention program

Sinovac first quarter sales increase 30.3% to $6.0M

Sinovac first quarter sales increase 30.3% to $6.0M

New Liquid ready-to-use Tumour Marker Control available now from Randox

New Liquid ready-to-use Tumour Marker Control available now from Randox

Researchers find protein that controls neurotransmission: findings may lead to new drugs to treat neurological disorders

Researchers find protein that controls neurotransmission: findings may lead to new drugs to treat neurological disorders

Many men do not protect their skin from sun exposure

Many men do not protect their skin from sun exposure

Health care system should provide proactive interventions to prevent depression

Health care system should provide proactive interventions to prevent depression

Changes in the temperature of foods can affect taste intensity

Changes in the temperature of foods can affect taste intensity

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.